Literature DB >> 12620237

EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.

Kathryn M Ferguson1, Mitchell B Berger, Jeannine M Mendrola, Hyun Soo Cho, Daniel J Leahy, Mark A Lemmon.   

Abstract

Epidermal growth factor (EGF) receptor is the prototype of the ErbB (HER) family receptor tyrosine kinases (RTKs), which regulate cell growth and differentiation and are implicated in many human cancers. EGF activates its receptor by inducing dimerization of the 621 amino acid EGF receptor extracellular region. We describe the 2.8 A resolution crystal structure of this entire extracellular region (sEGFR) in an unactivated state. The structure reveals an autoinhibited configuration, where the dimerization interface recently identified in activated sEGFR structures is completely occluded by intramolecular interactions. To activate the receptor, EGF binding must promote a large domain rearrangement that exposes this dimerization interface. This contrasts starkly with other RTK activation mechanisms and suggests new approaches for designing ErbB receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620237     DOI: 10.1016/s1097-2765(03)00047-9

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  278 in total

1.  Targeting the dimerization of epidermal growth factor receptors with small-molecule inhibitors.

Authors:  Robert Y C Yang; Katherine S Yang; Linda J Pike; Garland R Marshall
Journal:  Chem Biol Drug Des       Date:  2010-05-04       Impact factor: 2.817

2.  Epidermal growth factor receptor downregulation by small heterodimeric binding proteins.

Authors:  Benjamin J Hackel; Jason R Neil; Forest M White; K Dane Wittrup
Journal:  Protein Eng Des Sel       Date:  2011-12-09       Impact factor: 1.650

3.  Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.

Authors:  Zhiyong Zhang; Willy Wriggers
Journal:  Biochemistry       Date:  2011-02-18       Impact factor: 3.162

Review 4.  Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling.

Authors:  Joyce A Schroeder; Leslie F Jackson; David C Lee; Todd D Camenisch
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

5.  Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor.

Authors:  Katherine S Yang; Ma Xenia G Ilagan; David Piwnica-Worms; Linda J Pike
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

Review 6.  EGFR-targeted therapies in the post-genomic era.

Authors:  Mary Jue Xu; Daniel E Johnson; Jennifer R Grandis
Journal:  Cancer Metastasis Rev       Date:  2017-09       Impact factor: 9.264

Review 7.  Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.

Authors:  Kathryn M Ferguson; Chun Hu; Mark A Lemmon
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

Review 8.  Mechanisms of tumor resistance to EGFR-targeted therapies.

Authors:  Elizabeth A Hopper-Borge; Rochelle E Nasto; Vladimir Ratushny; Louis M Weiner; Erica A Golemis; Igor Astsaturov
Journal:  Expert Opin Ther Targets       Date:  2009-03       Impact factor: 6.902

9.  Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.

Authors:  Juan Felipe Franco-Gonzalez; Javier Ramos; Victor L Cruz; Javier Martínez-Salazar
Journal:  J Mol Model       Date:  2012-10-23       Impact factor: 1.810

10.  Single-Molecule Fluorescence Detection of the Epidermal Growth Factor Receptor in Membrane Discs.

Authors:  Steven D Quinn; Shwetha Srinivasan; Jesse B Gordon; Wei He; Kermit L Carraway; Matthew A Coleman; Gabriela S Schlau-Cohen
Journal:  Biochemistry       Date:  2018-04-06       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.